Enrolling
CTN 326: LIVEHIV Cohort Plus
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
Learn MoreEnrolling
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
Learn MoreResults
Evaluation of E/C/F/TAF switch followed by ledipasivir-sofosbuvir antiviral HCV therapy in HIV-HCV co-infection
Learn MoreResults
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals.
Learn MoreEnrolling
A prospective clinical cohort of HIV and hepatitis C virus co-infected patients
Learn MoreOngoing
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
Learn MoreReporting
Use of non-invasive methods for diagnosis of non-alcoholic steatohepatitis (NASH) in HIV patients and therapeutic use of vitamin E
Learn MoreTerminated
Can metformin prevent the progression of liver fibrosis in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance?
Learn MoreTerminated
An observational study of Kaletra®/Celsentri® combination therapy
Learn More